We found that loss of only one Pten allele was sufficient to substantially increase MTA1 both at protein and mRNA levels (Figure 1A–1C), suggesting that MTA1 may be involved in the initiation stage of prostate cancer. This evidence concerns the gene MTA1 and prostate carcinoma.